1.
Rituximab to Abbreviate Plasma Exchange in Anti-CFH (Complement Factor H) Antibody Mediated Atypical HUS. IJKD [Internet]. 2019 Apr. 15 [cited 2024 May 19];13(2):134-8. Available from: https://www.ijkd.org/index.php/ijkd/article/view/4138